Key metrics and charts across all fundamental categories.
Stock price and market valuation
CRS trades at $580.95, a 220.6% increase year-over-year. Market capitalization stands at $29.05B, up 219.4% from the prior year. Track CRS price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$3.03B in TTM revenue grew 3.7% YoY, reaching $811.50M last quarter. TTM EBITDA of $790.90M on operating income of $186.50M shows growth is flowing through. Net income of $479.10M TTM confirms the company is converting revenue into profit. Revenue is growing modestly — monitor for acceleration or deceleration.
Assets, cash, debt, and leverage
With $3.68B in assets and $690.40M in long-term debt, the D/E of 0.3 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 60.6x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 9.6x and P/B of 14.0x provide additional context. The premium P/E is not backed by strong revenue growth — the stock may be overvalued.
Operating efficiency and return metrics
Op. margin of 23.0% is up 4.0% YoY — cost efficiency is improving. Net margin at 17.2% and gross margin of 31.0%. ROE of 23.2% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $124.80M on $193.50M in operating cash flow. The FCF / Net Income ratio of 0.3x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $294.80M provide financial flexibility. Share count is stable — no dilution or buyback activity.
